GKB Ophthalmics Reports Strong Sales Growth Amid Cash Flow Challenges in August 2025

GKB Ophthalmics, a microcap player in the healthcare services industry, has recently reported its financial results for the quarter ending June 2025. The results, declared on August 14, 2025, indicate a notable adjustment in evaluation, with the score rising to 3 from a previous -5 over the last three months.
The financial data reveals some positive trends for GKB Ophthalmics. The company achieved its highest quarterly net sales in the last five quarters, reaching Rs 32.31 crore, suggesting a favorable near-term sales trajectory. Additionally, the Debtors Turnover Ratio has improved, recorded at 4.28 times over the last half-year periods, indicating that the company is effectively managing its receivables.

Conversely, there are challenges reflected in the financials. The annual operating cash flow has reached its lowest point in three years at Rs -3.43 crore, highlighting a decline in cash revenues from business operations. Furthermore, cash and cash equivalents have also fallen to Rs 13.82 crore, marking the lowest level in the last six half-year periods, which raises concerns about short-term liquidity.

For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.